2m 2m 2m 2m 2m 2m 2m
Pacific Bio CA (PACB)
NASDAQ
$1.31-$0.01 (-0.76%)
Price as of Jun 23, 2026 7:54 PM EDT- $410.0MMarket Cap
- 10.92%1-Year Change
- Medical DevicesIndustry
Pacific Bio CA (PACB)
$1.31-$0.01 (-0.76%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 135.8M -11.85% | 154.0M -23.19% | 200.5M +56.29% | 128.3M -1.69% | |
Cost of Revenue | 114.2M -2.15% | 116.7M -20.99% | 147.7M +86.38% | 79.3M +10.63% | |
Gross Profit | 45.8M +22.79% | 37.3M -29.36% | 52.8M +7.64% | 49.0M -16.69% | |
Sales and Marketing Expense | 141.5M -19.15% | 175.0M +3.06% | 169.8M +5.57% | 160.9M +29.59% | |
Research and Development Expense | -97.3M -27.88% | -134.9M -27.91% | -187.2M -196.98% | 193.0M +70.95% | |
Depreciation and Amortization Expense | 369.4M +1,247.76% | 27.4M +139.13% | 11.5M +20.92% | 9.5M +31.68% | |
Total Operating Expenses | 599.6M +17.21% | 511.6M +32.11% | 387.2M +8.71% | 356.2M +32.28% | |
Operating Profit | -553.9M +16.77% | -474.3M +41.81% | -334.5M +8.88% | -307.2M +45.98% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -7.0M -0.09% | -7.0M -50.98% | -14.3M -2.36% | -14.7M +17.24% | |
Interest Income and Expense and Net | -7.0M -0.09% | -7.0M -50.98% | -14.3M -197.64% | 14.7M +17.24% | |
Total Nonoperating Income and Expense | 14.8M -37.95% | 23.8M -27.23% | 32.7M +327.91% | 7.6M +8,112.90% | |
Income before Taxes | -546.1M +76.41% | -309.5M -2.71% | -318.2M +1.24% | -314.2M +14.33% | |
Income Taxes | 318,000 +0.63% | 316,000 +102.77% | -11.4M -87.80% | -93.6M 0.00% | |
Extraordinary Items | 0 -100.00% | 154.4M N/A | N/A N/A | N/A N/A | |
Net Income | -546.4M +76.34% | -309.9M +1.02% | -306.7M -2.39% | -314.2M +73.40% | |
Net Income from Continuing Operations Applicable to Common | -546.1M +76.41% | -309.5M -2.71% | -318.2M +1.24% | -314.2M +14.33% | |
Basic EPS and Net Income | -1.82 +61.06% | -1.13 -6.61% | -1.21 -13.57% | -1.40 +57.30% | |
Diluted EPS and Net Income | -1.82 +14.47% | -1.59 +31.40% | -1.21 -13.57% | -1.40 +57.30% | |
Basic Weighted Average Shares | 300.0M +9.28% | 274.5M +8.22% | 253.6M +12.95% | 224.6M +10.00% | |
Diluted Weighted Average Shares | 300.0M +4.02% | 288.4M +13.70% | 253.6M +12.95% | 224.6M +10.00% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 63.7M +15.06% | 55.4M -69.22% | 179.9M -44.66% | 325.1M -29.44% | |
Short-Term Investments | 215.8M -35.50% | 334.6M -25.90% | 451.5M +0.96% | 447.2M -23.38% | |
Cash and Cash Equivalents and Short-Term Investments | 279.5M -28.32% | 389.9M -38.24% | 631.4M -18.24% | 772.3M -26.05% | |
Total Current Assets | 375.1M -24.34% | 495.7M -33.20% | 742.0M -12.91% | 852.1M -22.62% | |
Accumulated Depreciation | 92.5M +12.84% | 81.9M +9.56% | 74.8M +15.09% | 65.0M +15.46% | |
Property and Plant and Equipment and Net | 24.1M -20.85% | 30.5M -16.27% | 36.4M -12.38% | 41.6M +27.92% | |
Total Long-Term Assets | 8.8M -5.72% | 9.3M -29.90% | 13.3M +26.08% | 10.5M +799.83% | |
Total Assets | 784.1M -37.79% | 1.3B -27.81% | 1.7B -1.19% | 1.8B -11.95% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 0 -100.00% | 490,000 -86.55% | 3.6M +127.63% | |
Total Current Liabilities | 72.8M +9.85% | 66.3M -30.23% | 95.0M -63.91% | 263.3M +267.23% | |
Total Long-Term Debt | 645.4M -0.33% | 647.5M -27.43% | 892.2M -0.50% | 896.7M +0.07% | |
Total Long-Term Liabilities | 0 -100.00% | 546,000 -27.30% | 751,000 -42.23% | 1.3M -62.55% | |
Total Liabilities | 778.7M +3.30% | 753.9M -27.84% | 1.0B -13.24% | 1.2B -0.97% | |
Retained Earnings | -2.7B +25.43% | -2.1B +16.85% | -1.8B +20.02% | -1.5B +25.80% | |
Total Stockholders Equity | 5.3M -98.94% | 506.6M -27.76% | 701.3M +24.59% | 562.9M -28.84% | |
Total Shares Outstanding | 302.0M +2.56% | 294.4M +9.96% | 267.7M +18.21% | 226.5M +2.50% | |
Cash Flow | |||||
Cash from Operating Activities | -111.2M -46.03% | -206.1M -20.49% | -259.2M -1.53% | -263.2M +136.74% | |
Capital Expenditures | 2.7M -56.14% | 6.2M -30.02% | 8.8M -47.21% | 16.8M +182.41% | |
Cash from Investing Activities | 115.4M -6.90% | 124.0M +2,593.40% | 4.6M -96.03% | 116.1M +117.11% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 3.4M +107.97% | -43.0M -139.48% | 108.9M +1,031.69% | 9.6M -99.18% | |
Financials Ratio | |||||
Gross Margin | 15.86% -34.48% | 24.21% -8.03% | 26.32% -31.13% | 38.22% -15.26% | |
Operating Margin | -407.98% +32.47% | -307.97% +84.63% | -166.80% -30.33% | -239.43% +48.49% | |
Return on Assets | -53.45% +159.30% | -20.61% +18.04% | -17.46% +4.86% | -16.65% +11.23% | |
Return on Equity | -213.45% +316.05% | -51.30% +5.73% | -48.53% +4.53% | -46.42% +44.28% | |
Revenue Growth | -11.85% -48.89% | -23.19% -141.21% | 56.29% +3,425.41% | -1.69% -102.59% | |
Current Ratio | 5.15 -31.12% | 7.48 -4.25% | 7.81 +141.33% | 3.24 -78.93% | |
Cash Ratio | 0.87 +4.73% | 0.84 -55.88% | 1.89 +53.36% | 1.23 -80.79% | |
Debt-to-Equity Ratio | N/A N/A | 1.28 +0.40% | 1.27 -20.41% | 1.60 +40.93% | |
Debt-to-Assets Ratio | N/A N/A | 0.51 +0.47% | 0.51 +0.35% | 0.51 +13.91% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow